Home – Loxapine Succinate
Loxapine Succinate
REMEDYREPACK INC.
FULL PRESCRIBING INFORMATION: CONTENTS*
FULL PRESCRIBING INFORMATION
BOXED WARNING
WARNING
WARNINGSLOXAPINE SUCCINATE DESCRIPTION
CLINICAL PHARMACOLOGY
INDICATIONS & USAGE
LOXAPINE SUCCINATE CONTRAINDICATIONS
WARNINGS
BOXED WARNINGADVERSE REACTIONSInformation for PatientsPRECAUTIONS
<%0A%09%09%09%09%09%09%09> <%0A%09%09%09%09%09%09%09> <%0A%09%09%09%09%09%09%09>INFORMATION FOR PATIENTS
DRUG INTERACTIONS
PREGNANCY
NURSING MOTHERS
PEDIATRIC USE
LOXAPINE SUCCINATE ADVERSE REACTIONS
WARNINGSOVERDOSAGE
DOSAGE & ADMINISTRATION
HOW SUPPLIED
STORAGE AND HANDLING
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION
Loxapine Succinate
Loxapine Succinate CAPSULE
Product Information
|
|
Product Type
|
Human prescription drug label |
Item Code (Source)
|
NDC:49349-212(NDC:0591-0372) |
|
Route of Administration
|
ORAL |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
|
Ingredient Name
|
Basis of Strength
|
Strength
|
|
LOXAPINE SUCCINATE LOXAPINE |
|
50 mg
|
Product Characteristics
|
|
Color
|
Size
|
Imprint Code
|
Shape
|
|
blue |
18 mm |
WATSON;372 |
OVAL |
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
NDC:49349-212-02 |
30 in 1 BLISTER PACK |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
ANDA |
ANDA072062 |
2011-04-26 |
|
|
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
